Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI), continues to add significant value to its core business model with several key movements involving a proposed merger, new licensing agreements and formation of a specialized subsidiary.
Legalizing marijuana nationwide would create at least $132 billion in tax revenue and more than a million new jobs across the United States in the next decade, according to a new study.
Global Payout (OTC: GOHE) announced today that its majority-owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”) has established a strategic partnership with T&T Financial.
The turning tide in public sentiment and the advancement of legalization, both in Canada and throughout the world, are gradually destigmatizing marijuana use and giving rise to new cannabis subcultures and brands.
India Globalization Capital, Inc. (NYSE American: IGC) sees opportunities in 2018, primarily from the distribution, in Germany, of its cannabinoid-based therapies, including IGC-AD1 (Hyalolex).
PotNetwork Holding, Inc. (OTC: POTN), through wholly-owned subsidiary Diamond CBD, Inc., this morning reported revenues exceeding $1.6 million for the month of November.
In Canada, chronic pain affects 1.5 million people. As national and worldwide numbers in pain diagnoses continue to rise, innovators in the cannabis industry are developing promising therapies to address this growing market.
Through exacting scientific protocols, Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is about to radically change the understanding and applications of this millennia-old medicine.
A new report from market analyst the Brightfield Group, featured in Forbes, estimates that global sales of cannabis will climb to $31.4 billion by 2021.
On September 13, 2017, Cannevert Therapeutics Ltd. (“CTL”), the research arm of Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP), filed a provisional patent for the use of a specific strain of cannabis to enhance the actions of opioid analgesics.
One area of the industry that appears to offer significant growth potential is the application of bitcoin and other cryptocurrencies to sectors of the economy, such as the cannabis industry.
Rade Kovacevic is a cannabis connoisseur. As the head of customer experience at Canopy Growth Corporation, a cannabis producer in Ontario, Canada, his job is to make sure his firm provides the highest quality marijuana. His company produces medicinal cannabis for patients across Canada, where recreational use is illegal but doctors can prescribe it to patients for medical purposes, such as pain management.
Invisicare®, a proprietary topical drug delivery technology developed by Skinvisible, Inc. has a potentially wide range of applications in the cannabis market.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) director Aaron Keay said in an interview with CannabisFN (CFN Media) that besides achieving greater market share in Canada, ABcann Global also sees opportunities for growth and presence in Western Europe, Germany and South America.
The company’s most recent research and development focus continues to be on readying a line of cannabis-based products targeting Alzheimer’s disease.
